SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

RIGBY JONATHAN

(Last)

(First)

(Middle)

C/O STEADYMED THERAPEUTICS, INC

2410 CAMINO RAMON

(Street)

SAN RAMON

94583

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/19/2015

3. Issuer Name and Ticker or Trading Symbol
SteadyMed Ltd. [ STDY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Rt to Buy)	⁽¹⁾	08/11/2018	Ordinary Shares	88,831	$3.61	D
Stock Option (Rt to Buy)	⁽²⁾	07/19/2019	Ordinary Shares	152,342	$3.61	D
Stock Option (Rt to Buy)	⁽³⁾	05/01/2020	Ordinary Shares	18,515	$3.61	D
Stock Option (Rt to Buy)	⁽⁴⁾	07/07/2021	Ordinary Shares	108,702	$3.61	D
Stock Option (Rt to Buy)	⁽⁵⁾	07/07/2021	Ordinary Shares	36,510	$3.61	D
Stock Option (Rt to Buy)	⁽⁶⁾	01/25/2022	Ordinary Shares	131,541	$5.84	D
Stock Option (Rt to Buy)	⁽⁷⁾	02/14/2020	Ordinary Shares	3,875	$3.61	I	By Spouse
Stock Option (Rt to Buy)	⁽⁸⁾	01/25/2022	Ordinary Shares	3,875	$5.84	I	By Spouse

Explanation of Responses:

1. Fully vested.

2. 1/3rd of the Option Shares shall vest on July 19, 2013. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on October 19, 2013 until fully vested.

3. 1/3rd of the Option Shares shall vest on May 1, 2014. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on September 30, 2014 until fully vested.

4. 1/3rd of the Option Shares shall vest on February 24, 2015. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on June 30, 2015 until fully vested.

5. 1/3rd of the Option Shares shall vest on February 24, 2015. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on June 30, 2015 until fully vested.

6. 1/3rd of the of the Option Shares shall vest on January 28, 2016. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on March 1, 2016 until fully vested.

7. 1/3rd of the Option Shares shall vest on February 14, 2013. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on May 14, 2013 until fully vested.

8. 1/3rd of the Option Shares shall vest on January 28, 2016. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on March 1, 2016 until fully vested.

Remarks:

President and Chief Executive Officer

	/s/ Michael E. Tenta, Attorney-In-Fact	03/19/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.